ALS Community Urges FDA to Act on Treatment Access, Research Support

ALS Community Urges FDA to Act on Treatment Access, Research Support

295398

ALS Community Urges FDA to Act on Treatment Access, Research Support

People living with amyotrophic lateral sclerosis (ALS) recently shared their views on the importance of new therapies and incremental gains, and the risks they are willing to take with U.S. Food and Drug Administration (FDA) and industry officials in a virtual meeting hosted by The ALS Association. The “We Can’t Wait Action Meeting” was about “ensuring FDA officials and industry have a clear understanding of how our community values the potential for any benefit, small…

You must be logged in to read/download the full post.